PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17697615-13 2007 Inhibitors specific for the JNK (SP600125), MEK (PD98059), and p38 MAPK (SB203580), abrogated HMGB1-induced TNF-alpha secretion. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 49-56 high mobility group box 1 Homo sapiens 94-99 23628898-7 2013 One of the mechanisms underlying these activating effects of ICs on human endothelial cells involves cell signaling by high-mobility group box 1 protein (HMGB1)-RAGE axis, as these effects can be partially blocked by HMGB1 A-box, soluble RAGE (sRAGE), SB203580, PD98059, Bay 117082 (P<0.05) and co-treatment with these agents (P<0.05). 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 262-269 high mobility group box 1 Homo sapiens 119-144 23628898-7 2013 One of the mechanisms underlying these activating effects of ICs on human endothelial cells involves cell signaling by high-mobility group box 1 protein (HMGB1)-RAGE axis, as these effects can be partially blocked by HMGB1 A-box, soluble RAGE (sRAGE), SB203580, PD98059, Bay 117082 (P<0.05) and co-treatment with these agents (P<0.05). 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 262-269 high mobility group box 1 Homo sapiens 154-159 21116767-8 2011 A series of RAGE and HMGB1 co-immunoprecipitation experiments in the presence of SB203580 and PD98059 (p38 MAPK and ERK inhibitors, respectively) demonstrated that RAGE-p38 MAPK and RAGE-ERK pathway might underlie extracellular HMGB1-mediated neuronal apoptosis. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 94-101 high mobility group box 1 Homo sapiens 21-26 19588230-7 2009 The HMGb1-induced increases of cell proliferation, cell migration, and wound closure were abolished by the MEK inhibitor PD98059. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 121-128 high mobility group box 1 Homo sapiens 4-9 32471717-6 2020 Similarly, inhibition for ERK (PD98059), NF-kappaB (BAY11-7082) and c-Jun (c-Jun peptide), respectively, also suppressed the HMGB1 cytoplasm translocation. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 31-38 high mobility group box 1 Homo sapiens 125-130 17135572-5 2007 Inhibitors specific for the JNK (SP600125) and MEK (PD98059), but not p38 MAPK (SB203580), abrogated H(2)O(2)-induced, active HMGB1 release. 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 52-59 high mobility group box 1 Homo sapiens 126-131